Top

BY Kellie Bramlet

Hyperthermic intraperitoneal chemotherapy (HIPEC) is a type of cancer treatment in which surgeons apply heated chemotherapy after surgically removing tumors. This innovative method is used to treat mesothelioma, appendix, colorectal and other types of cancer.

Recently, Brian Badgwell, M.D.,  professor of Surgical Oncology, used HIPEC in a Phase II clinical trial...

Surgeons have used heated chemotherapy to treat appendix

BY Sarah Zizinia

Combining a 3D virtual cutting guide with a surgical navigation tool allowed MD Anderson surgeons to perform a complicated pelvic reconstruction...

BY Clayton Boldt, Ph. D.

Results from two MD Anderson-led clinical trials indicate that targeted therapies led to significant improvements in progression-free survival...

BY Ron Gilmore

The addition of nivolumab to induction chemotherapy with idarubicin and cytarabine is feasible in patients with newly diagnosed acute myeloid leukemia (AML) or high-risk myelodysplastic syndrome (MDS), according to findings from a study at The University of Texas MD Anderson Cancer Center.

A study that enrolled 44 patients between August 2015 and June 2018 reported on its findings this month online at The Lancet Haematology. The...

Farhad Ravandi, M.D., led the clinical trial that paired the immune checkpoint inhibitor nivolumab with a chemotherapy combination for acute myeloid leukemia.

BY Clayton Boldt, Ph.D.

According to the Centers for Disease Control and Prevention, the human papillomavirus is responsible for roughly 33,700 new cancer cases each...

BY Ron Gilmore

A study at The University of Texas MD Anderson Cancer Center has shed information on a novel oncogenic pathway and points to the use of BET...

BY Clayton Boldt

Prostate cancer is the most common cancer diagnosed in American men, and the second leading cause of cancer death in men. While hormone-based...

BY Ron Gilmore

A randomized Phase III clinical trial combining two common chemotherapy agents as a pre-stem cell transplant treatment at The University of...

BY Scott Merville

Nationally, only about 9% of people diagnosed with pancreatic cancer survive five years. In most cases, the disease has spread to other organs...

BY Clayton Boldt, Ph.D.

Select breast cancer patients who after undergoing chemotherapy as their first line of treatment show no residual cancer – a state known as...